ArticleFrontiers in oncology2022
Development and validation of cuproptosis-associated prognostic signatures in WHO 2/3 glioma.
Zhang Ye et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this paperpooled itcites it